DSpace DSpace Softwareについて English
 

GINMU >
01 奈良県立医科大学 >
011 医学部 >
0112 紀要 >
01121 Journal of Nara Medical Association >
Vol.47 No.6 >

このアイテムの引用には次の識別子を使用してください: http://hdl.handle.net/10564/768

タイトル: 肺結核患者におけるサイトカイン産生能に関する研究 : 第1報 末梢血血清中のサイトカイン濃度の検討
その他のタイトル: STUDY ON CYTOKINE PRODUCTION OF PATIENTS WITH PULMONARY TUBERCULOSIS : 1. INVESTIGATION ON SERUM LEVELS OF CYTOKINES OF PATIENTS WITH PULMONARY TUBERCULOSIS
著者: 仲谷, 宗裕
キーワード: pulmonary tuberculosis
interleukin-8 (IL-8)
tumor necrosis factor-α (TNF-α)
tuberculous cavity
発行日: 1996年12月31日
出版者: 奈良医学会
引用: 奈良医学雑誌 Vol.47 No.6 p.384-389
抄録: Concentrations of IL-8 and TNF-α in the serum of 16 patients with active pulmonary tuberculosis (patients group) were measured by ELISA before the initiation of antituberculous therapy, and were compared with those measured in 20 age and smoking habit-matched healthy controls. The mean level of serum IL-8 in patients group was significantly higher than that of healthy controls (P<0.001). The mean level of serum TNF-α in tuberculosis patients was also high, while TNF-α was not measurable in the serum of healthy controls. The relationship between clinical pictures, defined mainly by radiographic findings, and the serum levels of IL-8 and TNF-α were examined. Serum IL-8 levels of 9 patients with cavity were significantly higher those that of 7 patients without cavity (P<0.05). Out of 9 patients with cavity, four patients with advanced lesions on chest rentogenogram had higher serum IL-8 levels then did the remaining 5 patients with moderate lesions (P< 0.05), but there was no correlation between TNF-α level and radiographic findings. Those results suggest that IL-8 appears to be involved in the formation of tuberculous cavitary lesion.
URI: http://hdl.handle.net/10564/768
ISSN: 04695550
13450069
出現コレクション:Vol.47 No.6

このアイテムのファイル:

ファイル 記述 サイズフォーマット
384-389p.肺結核患者におけるサイトカイン産生能に関する研究.pdf673.22 kBAdobe PDF見る/開く

このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。

 

Valid XHTML 1.0! Powered by DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - ご意見をお寄せください